Home
>
Stocks
>
Laurus Labs Limited

Laurus Labs Limited

LAURUSLABS

317.40
9.45
(
2.89
%)
1D

Performance

Today's High
328.95
Today's Low
317.00
52W High
52.0
52W Low
52.0
Open Price
52.0
Prev. Close
52.10
Volume
52.0
Value
522 Cr.

Fundamentals

Market Cap
₹39,910Cr
P/E Ratio(TTM)
NA
P/B ratio
2.21
Industry P/E
-2.47
Debt to Equity
0.03
ROE
-10.01%
EPS(TTM)
-1.13
EPS(TTM)
-1.13
Book Value
25.84
Face Value
1

About

Laurus Labs Limited

Laurus Labs Limited, together with its subsidiaries, engages in the development, manufacture, and sale of medicines and active pharmaceutical ingredients (APIs) in India and internationally. The company develops, manufactures, and sells APIs and advanced intermediates for anti-retroviral (ARV), antidiabetic, cardiovascular, proton pump inhibitors (PPIs), oncology, gastroenterology, and hepatitis C therapeutic areas. It also develops and manufactures oral solid formulations for ARVs, anti-diabetic, cardiovascular, PPIs, and central nervous system. In addition, the company provides contract development and manufacturing services for pharmaceutical companies; and manufactures and sells specialty ingredients used in the nutraceutical, dietary supplements, and cosmeceutical products. Further, it develops novel enzymatic solutions for industrial biotechnology, and animal origin free recombinant proteins and enzymes for biopharma; and offers business support services for pharmaceutical field. The company was incorporated in 2005 and is based in Hyderabad, India.

ITC
2
HDFC Bank
2
Tata Consultancy Services
1
Top Gainers
Tata motors
1.28
SAIL
2.00
Gail
2.80
Top Losers
Britannia
-2
Adani
2